Expertvet India Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 0.55 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Net Worth -242.56%
- Total Assets 108.40%
About Expertvet India Bio Sciences
Expertvet India Bio Sciences Private Limited (EIBSPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 October 2015 (Nine years and four months 2 days old ). Its registered office is in Dharwad, Karnataka, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 0.55 M, as per Ministry of Corporate Affairs (MCA) records.
Lingaraj Hugar, Prasanna Raviraj, Gopal Neladurg, and Three other members serve as directors at the Company.
Company Details
-
Location
Dharwad, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900KA2015PTC083301
-
Company No.
083301
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Oct 2015
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Expertvet India Bio Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumarswamy Neldurg
|
Managing Director | 09-Oct-2015 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Gopal Neladurg
|
Director | 14-Dec-2015 | Current |
|
Lingaraj Hugar
|
Director | 14-Dec-2015 | Current |
|
Prasanna Raviraj
|
Director | 14-Dec-2015 | Current |
|
Shashikant Onkari
|
Director | 14-Dec-2015 | Current |
|
Yashoda Neldurg
|
Director | 09-Oct-2015 | Current |
Financial Performance of Expertvet India Bio Sciences.
Expertvet India Bio Sciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 242.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Expertvet India Bio Sciences?
In 2017, Expertvet India Bio Sciences had a promoter holding of 29.09% and a public holding of 70.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Expertvet India Bio Sciences?
Unlock and access historical data on people associated with Expertvet India Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Expertvet India Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Expertvet India Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
